🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

(1) This is an amazing paper on the limitations of (current) single-cell foundation models "Our results indicate that both Geneformer and scGPT exhibit limited reliability in zero-shot settings and often underperform compared to simpler methods." biorxiv.org/content/10.110…

Enjoying great cancer genomics science 🤩 with Genome Data Science lab in Heidelberg📍 #EMBLCanGen

Exciting find in our #OralCancer study! 🧬 Brush biopsies prove promising, reflecting 90% of somatic changes vs. tissue biopsies. 🩸 Highlighting their potential in understanding tumor evolution. #CancerEvolution biorxiv.org/content/10.110…

🔍🧬#IRBBarcelona researchers discover unexpected patterns in mutation risks across individuals, uncovering 13 distinct genomic patterns. ✍️Dr Fran Supek & Marina Salvadores Ferreiro (Genome Data Science lab). 📰Nature Cancer ➡️bit.ly/3tVjxJT 📌DOI:10.1038/S43018-023-00707-8 #IRBScience

Excited to share my PhD journey exploring NMD efficiency's variability across tumors, tissues and individuals. Link: biorxiv.org/content/10.110… A big thank you to Fran Supek and the awesome lab Genome Data Science lab at IRB Barcelona 1/7🧵👇

🎉Liza's paradoxical paper is out in Nature Comms: nature.com/articles/s4146… The short of it: ➡️driver CNA gains in tumor suppressor genes ➡️driver CNA losses in oncogenes ➡️some negative selection on oncogenes + comprehensive, data driven classification of cancer genes by CNA

💊The #DocTISProject, dedicated to identifying more effective therapies for #IMIDs, will host a webinar on February 6th. 🎤 Speakers will be: - Sara Marsal - Holger Heyn - Ernest Choy - Pere Santamaria - Maria López Lasanta - Antonio Julià 👉 Register here: attendee.gotowebinar.com/register/87088…

Great insights about our recent publication in Nature Communications!